Stop TB says the price of J&J's tuberculosis treatment bedaquiline drops 55%
31 Aug 2023
The Stop TB Partnership announced a 55% decrease in the price for Johnson & Johnson’s version of bedaquiline known as Sirturo, which is used to treat drug-resistant tuberculosis.
The Swiss nonprofit’s supply and procurement arm, known as the Global Drug Facility (GDF), said the drug now costs around $130 per six-month treatment course. The organization also secured a 33% price reduction for Lupin’s generic version of the drug for $194 for six months of treatment.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.